phase readout
saveNCT07489573: Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa
RECRUITINGupdated 21h ago
community read0 votes
Sponsor: Novartis Pharmaceuticals. Phase: PHASE4. Conditions: Hidradenitis Suppurativa (HS)
view source ↗
comments(0)
5-min edit window · permanent after that